DK0983273T3 - Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler - Google Patents

Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler

Info

Publication number
DK0983273T3
DK0983273T3 DK98921294T DK98921294T DK0983273T3 DK 0983273 T3 DK0983273 T3 DK 0983273T3 DK 98921294 T DK98921294 T DK 98921294T DK 98921294 T DK98921294 T DK 98921294T DK 0983273 T3 DK0983273 T3 DK 0983273T3
Authority
DK
Denmark
Prior art keywords
ethylene glycol
glycol esters
photoactive agents
monohydrobenzoporphyrin
derivatives
Prior art date
Application number
DK98921294T
Other languages
Danish (da)
English (en)
Inventor
Ethan Sternberg
Anna M Richter
David W C Hunt
Jain Ashok
David Dolphin
Julia G Levy
Ashok Jain
Elizabeth M Waterfield
Original Assignee
Univ British Columbia
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia, Quadra Logic Tech Inc filed Critical Univ British Columbia
Application granted granted Critical
Publication of DK0983273T3 publication Critical patent/DK0983273T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK98921294T 1997-05-07 1998-05-06 Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler DK0983273T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85249497A 1997-05-07 1997-05-07
PCT/CA1998/000468 WO1998050387A1 (en) 1997-05-07 1998-05-06 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents

Publications (1)

Publication Number Publication Date
DK0983273T3 true DK0983273T3 (da) 2002-04-22

Family

ID=25313492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98921294T DK0983273T3 (da) 1997-05-07 1998-05-06 Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler

Country Status (21)

Country Link
US (2) US5929105A (pt)
EP (2) EP0983273B8 (pt)
JP (1) JP3378889B2 (pt)
KR (1) KR100397131B1 (pt)
CN (1) CN1113882C (pt)
AR (1) AR012673A1 (pt)
AT (1) ATE211473T1 (pt)
AU (1) AU741070B2 (pt)
CA (1) CA2284879C (pt)
CZ (1) CZ294715B6 (pt)
DE (1) DE69803376T2 (pt)
DK (1) DK0983273T3 (pt)
ES (2) ES2171022T3 (pt)
HK (1) HK1042439B (pt)
HU (1) HU221754B1 (pt)
IL (1) IL132066A (pt)
NO (1) NO314264B1 (pt)
NZ (1) NZ338031A (pt)
PL (1) PL202341B1 (pt)
PT (1) PT983273E (pt)
WO (1) WO1998050387A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756396B1 (en) * 1997-05-07 2004-06-29 Qlt Inc. Ethylene glycol esters as photoactive agents
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6331235B1 (en) * 1998-12-11 2001-12-18 The University Of British Columbia Chiral separation of benzoporphyrin derivative mono-and di-acids by laser-induced fluorescence capillary electrophoresis
US6344050B1 (en) 1998-12-21 2002-02-05 Light Sciences Corporation Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
CA2356532A1 (en) * 1999-01-15 2000-07-20 Light Sciences Corporation Noninvasive vascular therapy
AU2789900A (en) * 1999-02-26 2000-09-21 Qlt Phototherapeutics, Inc. Photodynamic therapy in combination with apoptosis inducing factors
GB9905911D0 (en) * 1999-03-15 1999-05-05 Photocure As Method
US6609014B1 (en) 1999-04-14 2003-08-19 Qlt Inc. Use of PDT to inhibit intimal hyperplasia
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
US7122568B1 (en) 1999-11-17 2006-10-17 Qlt, Inc. Use of low-dose PDT to inhibit restenosis
US20020049247A1 (en) * 2000-01-12 2002-04-25 Chen James C. Novel treatment for eye disease
AU2001258117A1 (en) 2000-05-08 2001-11-20 The University Of British Columbia Supports for photosensitizer formulations
WO2001085212A2 (en) * 2000-05-08 2001-11-15 The University Of British Columbia Drug delivery systems for photodynamic therapy
AU2210402A (en) * 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for virus-mediated molecule delivery into the cyosol
CN100558903C (zh) * 2000-11-29 2009-11-11 Pci生物技术联合股份有限公司 将分子输递进胞质溶胶的光化学内化法
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
JP2004532251A (ja) * 2001-05-31 2004-10-21 ミラヴァント ファーマシューティカルズ インコーポレイテッド 光線力学療法で使用のメタロテトラピロール系光増感剤
DE60230636D1 (de) * 2001-08-22 2009-02-12 Univ Montana State Porphyrine mit verbesserten multi-photonen-absorptionsquerschnitten für die photodynamische therapie
ATE390121T1 (de) * 2001-11-02 2008-04-15 Univ Alberta Micelle-zusammensetzungen enthaltend pegylierten phospholipide und einen photosensibilisator
US7264629B2 (en) 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
ATE386544T1 (de) * 2001-11-09 2008-03-15 Quadra Logic Tech Inc Photodynamische therapie zur behandlung von haarausfall
CA2437638A1 (en) * 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
US20120034156A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
CA2766643C (en) 2009-07-08 2017-01-03 Dermira (Canada), Inc. Tofa analogs useful in treating dermatological disorders or conditions
AU2011213678B2 (en) 2010-02-04 2015-01-29 Eisai Inc. Chlorotoxin polypeptides and conjugates and uses thereof
MX2013008175A (es) 2011-01-13 2013-12-16 Quadra Logic Tech Inc Composiciones farmacéuticas para suministro tópico de fotosensibilizadores y usos de los mismos.
WO2013003507A1 (en) 2011-06-27 2013-01-03 Morphotek, Inc. Multifunctional agents
WO2013063312A1 (en) 2011-10-25 2013-05-02 Memorial Sloan-Kettering Cancer Center Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
JP2015522079A (ja) 2012-07-11 2015-08-03 ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． 光線感作物質の局所送達のための医薬組成物及びその使用
CA2889756C (en) 2012-10-26 2023-03-14 Memorial Sloan-Kettering Cancer Center Thiohydantoin compounds as androgen receptor modulators
CA2934524C (en) 2013-12-23 2022-02-15 Memorial Sloan-Kettering Cancer Center Methods and compositions for treating cancer using peptide nucleic acid-based agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5171749A (en) 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US4883790A (en) 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
CA2056431A1 (en) * 1989-06-07 1990-12-08 David Dolphin Photosensitizing diels-alder porphyrin derivatives
US5498710A (en) * 1994-04-22 1996-03-12 Health Research, Inc. Alkyl ether analogues of benzoporphyrin derivatives
CN1120166C (zh) * 1997-05-07 2003-09-03 不列颠哥伦比亚省大学 新一类的苯并卟啉光活性化合物

Also Published As

Publication number Publication date
PL202341B1 (pl) 2009-06-30
EP0983273A1 (en) 2000-03-08
PT983273E (pt) 2002-06-28
KR20010012331A (ko) 2001-02-15
EP1177795A3 (en) 2002-05-29
EP1177795B1 (en) 2013-09-11
EP0983273B1 (en) 2002-01-02
DE69803376T2 (de) 2002-08-14
ATE211473T1 (de) 2002-01-15
AR012673A1 (es) 2000-11-08
NO995436L (no) 2000-01-04
KR100397131B1 (ko) 2003-09-13
ES2437790T3 (es) 2014-01-14
CZ392399A3 (cs) 2000-02-16
PL336790A1 (en) 2000-07-17
CN1113882C (zh) 2003-07-09
NO314264B1 (no) 2003-02-24
JP2001507369A (ja) 2001-06-05
IL132066A (en) 2008-06-05
CA2284879A1 (en) 1998-11-12
HK1042439B (zh) 2014-02-28
AU7420798A (en) 1998-11-27
HU221754B1 (hu) 2002-12-28
EP0983273B8 (en) 2002-10-09
DE69803376D1 (de) 2002-02-28
NZ338031A (en) 2001-04-27
EP1177795A2 (en) 2002-02-06
IL132066A0 (en) 2001-03-19
CA2284879C (en) 2005-10-25
AU741070B2 (en) 2001-11-22
CN1254339A (zh) 2000-05-24
US6153639A (en) 2000-11-28
US5929105A (en) 1999-07-27
CZ294715B6 (cs) 2005-02-16
NO995436D0 (no) 1999-11-05
JP3378889B2 (ja) 2003-02-17
HUP0003604A2 (hu) 2001-02-28
HUP0003604A3 (en) 2002-04-29
WO1998050387A1 (en) 1998-11-12
ES2171022T3 (es) 2002-08-16

Similar Documents

Publication Publication Date Title
DK0983273T3 (da) Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler
NO20014412L (no) Forbindelser nyttige som anti-inflammatoriske midler
NO20002173D0 (no) Pleuromutilin-derivater som antimikrobielle midler
NO20013559D0 (no) Aromatiske heterocykliske forbindelser som anti- inflammatoriske midler
NO20013671L (no) Substituerte bisycliske derivater nyttige som anticancer midler
NO20002217L (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
NO992725D0 (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
FI951001A (fi) Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina
NO971137L (no) Dimetyl-(3-aryl-but-3-enyl)-aminforbindelse som farmasöytiske forbindelser
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO990435L (no) Fremstilling av estere som overflateaktive midler
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
NO972887D0 (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
NO20020457D0 (no) Benzenaminderivater som antikoagulanter
DK1075471T3 (da) Idolylderivater som serotonerge midler
NO20001200D0 (no) Pyrrolopyrrolonderivater som inhibitorer av neurofil elastase
FI970727A0 (fi) Foerfarande och anordning foer torkning av objekt som innehaoller vatten
NO996244D0 (no) Pyrrolidinkarboksylsyrederivater som endotelinantagonister
NO20002321D0 (no) Bifenylderivater som farmasøytiske midler
NO972905D0 (no) Tienoksasinon-derivater anvendelige som antivirusmidler
FI980557A0 (fi) Foerfarande vid kalandrering av pappersbana och kalander som tillaempar foerfarandet
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
DK1216249T3 (da) Usubstituerede ethyl- og propylderivater af phenoxythienoisoxazoler som D4-antagonister
DK0980383T3 (da) Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener